🇮🇳IN
Sign In
ST

STAR

NSE

Strides Pharma Science Limited

₹1,097.50

+11.90(+1.10%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

STAR financial summary

For Mar 2026, Strides Pharma Science Limited reported revenue of ₹2,180 crore, which grew 1.9% from the previous year. Net profit was ₹184 crore, which fell 93.6% year on year, on an operating margin of 13%. Earnings per share came in at ₹19.92. Annual results are available for 14 financial years, from Dec 2012 to Mar 2026.

Revenue₹2,180 crore
Net profit₹184 crore
Operating margin13%
EPS₹19.92

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer